Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases

Journal of Neuroimmunology

Volumn 274, Issue 1-2, 2014, Pages 1-13

  González, Hugo ^a   Elgueta, Daniela ^a,b   Montoya, Andro ^a   Pacheco, Rodrigo ^a,c  

^a Fundacion Ciencia para la Vida   (Chile)

^b UNIVERSIDAD ANDRÉS BELLO   (Chile)

^c UNIVERSIDAD SAN SEBASTIÁN   (Chile)

Author keywords

Blood brain barrier; Microglia; Neo antigens; Neurodegenerative disorders; Neuroinflammation; T cells

Indexed keywords

ANTIGEN;

ADAPTIVE IMMUNITY; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTE; BLOOD BRAIN BARRIER; CELL ACTIVITY; CELL INTERACTION; DEGENERATIVE DISEASE; DISEASE COURSE; HUMAN; IMMUNOREGULATION; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

BLOOD-BRAIN BARRIER; MICROGLIA; NEO-ANTIGENS; NEURODEGENERATIVE DISORDERS; NEUROINFLAMMATION; T-CELLS;

ANIMALS; BLOOD-BRAIN BARRIER; HUMANS; IMMUNE TOLERANCE; MICROGLIA; NEURITIS; NEURODEGENERATIVE DISEASES; NEUROIMMUNOMODULATION;

EID: 84906934110     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.07.012     Document Type: Review

References (149)

1. Abbott N.J., Ronnback L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 2006, 7:41-53.
2. Alessandri B., Bullock R. Glutamate and its receptors in the pathophysiology of brain and spinal cord injuries. Prog. Brain Res. 1998, 116:303-330.
3. Anandasabapathy N., Victora G.D., Meredith M., Feder R., Dong B., Kluger C., et al. Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain. J. Exp. Med. 2011, 208:1695-1705.
4. Appel S.H. CD4+ T cells mediate cytotoxicity in neurodegenerative diseases. J. Clin. Invest. 2009, 119:13-15.
5. Badie B., Bartley B., Schartner J. Differential expression of MHC class II and B7 costimulatory molecules by microglia in rodent gliomas. J. Neuroimmunol. 2002, 133:39-45.
6. Balistreri C.R., Colonna-Romano G., Lio D., Candore G., Caruso C. TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases. J. Clin. Immunol. 2009, 29:406-415.
7. Barcia C., Ros C.M., Annese V., Gomez A., Ros-Bernal F., Aguado-Yera D., et al. IFN-gamma signaling, with the synergistic contribution of TNF-alpha, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease. Cell Death Dis. 2011, 2:e142.
8. Barger S.W., Basile A.S. Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J. Neurochem. 2001, 76:846-854.
9. Baruch K., Schwartz M. CNS-specific T cells shape brain function via the choroid plexus. Brain Behav. Immun. 2013, 34:11-16.
10. Bedi S.S., Smith P., Hetz R.A., Xue H., Cox C.S. Immunomagnetic enrichment and flow cytometric characterization of mouse microglia. J. Neurosci. Methods 2013, 219:176-182.
11. Benner E.J., Banerjee R., Reynolds A.D., Sherman S., Pisarev V.M., Tsiperson V., et al. Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons. PLoS One 2008, 3:e1376.
12. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., et al. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 2001, 4:702-710.
13. Bhaskar K., Konerth M., Kokiko-Cochran O.N., Cardona A., Ransohoff R.M., Lamb B.T. Regulation of tau pathology by the microglial fractalkine receptor. Neuron 2010, 68:19-31.
14. Biernacki K., Prat A., Blain M., Antel J.P. Regulation of Th1 and Th2 lymphocyte migration by human adult brain endothelial cells. J. Neuropathol. Exp. Neurol. 2001, 60:1127-1136.
15. Birnboim H.C., Lemay A.M., Lam D.K., Goldstein R., Webb J.R. Cutting edge: MHC class II-restricted peptides containing the inflammation-associated marker 3-nitrotyrosine evade central tolerance and elicit a robust cell-mediated immune response. J. Immunol. 2003, 171:528-532.
16. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
17. Boka G., Anglade P., Wallach D., Javoy-Agid F., Agid Y., Hirsch E.C. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci. Lett. 1994, 172:151-154.
18. Brambilla R., Bracchi-Ricard V., Hu W.H., Frydel B., Bramwell A., Karmally S., et al. Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med. 2005, 202:145-156.
19. Burguillos M.A., Deierborg T., Kavanagh E., Persson A., Hajji N., Garcia-Quintanilla A., et al. Caspase signalling controls microglia activation and neurotoxicity. Nature 2011, 472:319-324.
20. Burzyn D., Benoist C., Mathis D. Regulatory T cells in nonlymphoid tissues. Nat. Immunol. 2013, 14:1007-1013.
21. Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S.M., Dijkstra I.M., et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 2006, 9:917-924.
22. Carpentier P.A., Begolka W.S., Olson J.K., Elhofy A., Karpus W.J., Miller S.D. Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 2005, 49:360-374.
23. Cayrol R., Wosik K., Berard J.L., Dodelet-Devillers A., Ifergan I., Kebir H., et al. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat. Immunol. 2008, 9:137-145.
24. Cheng N., He R., Tian J., Ye P.P., Ye R.D. Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J. Immunol. 2008, 181:22-26.
25. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988, 1:623-634.
26. Codarri L., Gyulveszi G., Tosevski V., Hesske L., Fontana A., Magnenat L., et al. RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 2011, 12:560-567.
27. Croisier E., Moran L.B., Dexter D.T., Pearce R.K., Graeber M.B. Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition. J. Neuroinflammation 2005, 2:14.
28. Damier P., Hirsch E.C., Zhang P., Agid Y., Javoy-Agid F. Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience 1993, 52:1-6.
29. Dardalhon V., Korn T., Kuchroo V.K., Anderson A.C. Role of Th1 and Th17 cells in organ-specific autoimmunity. J. Autoimmun. 2008, 31:252-256.
30. Dawson V.L., Dawson T.M., Bartley D.A., Uhl G.R., Snyder S.H. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 1993, 13:2651-2661.
31. Derecki N.C., Cardani A.N., Yang C.H., Quinnies K.M., Crihfield A., Lynch K.R., et al. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J. Exp. Med. 2010, 207:1067-1080.
32. DiCarlo G., Wilcock D., Henderson D., Gordon M., Morgan D. Intrahippocampal LPS injections reduce Abeta load in APP+PS1 transgenic mice. Neurobiol. Aging 2001, 22:1007-1012.
33. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.H., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 1993, 7:75-83.
34. Doi Y., Mizuno T., Maki Y., Jin S., Mizoguchi H., Ikeyama M., et al. Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid {beta} neurotoxicity in in vitro and in vivo models of Alzheimer's disease. Am. J. Pathol. 2009, 175:2121-2132.
35. Engelhardt B. Molecular mechanisms involved in T cell migration across the blood-brain barrier. J. Neural Transm. 2006, 113:477-485.
36. Eroglu C., Barres B.A. Regulation of synaptic connectivity by glia. Nature 2010, 468:223-231.
37. Farina C., Aloisi F., Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol. 2007, 28:138-145.
38. Ferrari C.C., Pott Godoy M.C., Tarelli R., Chertoff M., Depino A.M., Pitossi F.J. Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra. Neurobiol. Dis. 2006, 24:183-193.
39. + regulatory T cells. Nat. Immunol. 2003, 4:330-336.
40. Fountain N.B. Status epilepticus: risk factors and complications. Epilepsia 2000, 41(Suppl. 2):S23-S30.
41. Frank-Cannon T.C., Tran T., Ruhn K.A., Martinez T.N., Hong J., Marvin M., et al. Parkin deficiency increases vulnerability to inflammation-related nigral degeneration. J. Neurosci. 2008, 28:10825-10834.
42. Fujiwara H., Hasegawa M., Dohmae N., Kawashima A., Masliah E., Goldberg M.S., et al. Alpha-synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 2002, 4:160-164.
43. Gao H.M., Zhou H., Zhang F., Wilson B.C., Kam W., Hong J.S. HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration. J. Neurosci. 2011, 31:1081-1092.
44. Gauba V., Grunewald J., Gorney V., Deaton L.M., Kang M., Bursulaya B., et al. Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:12821-12826.
45. Giasson B.I., Duda J.E., Murray I.V., Chen Q., Souza J.M., Hurtig H.I., et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 2000, 290:985-989.
46. Gitik M., Liraz-Zaltsman S., Oldenborg P.A., Reichert F., Rotshenker S. Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPalpha (signal regulatory protein-alpha) on phagocytes. J. Neuroinflammation 2011, 8:24.
47. Glass C.K., Saijo K., Winner B., Marchetto M.C., Gage F.H. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140:918-934.
48. Goeb V., Thomas-L'Otellier M., Daveau R., Charlionet R., Fardellone P., Le Loet X., et al. Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes. Arthritis Res. Ther. 2009, 11:R38.
49. Gordon R., Anantharam V., Kanthasamy A.G., Kanthasamy A. Proteolytic activation of proapoptotic kinase protein kinase Cdelta by tumor necrosis factor alpha death receptor signaling in dopaminergic neurons during neuroinflammation. J. Neuroinflammation 2012, 9:82.
50. Goverman J. Autoimmune T, cell responses in the central nervous system. Nat. Rev. Immunol. 2009, 9:393-407.
51. Hagino Y., Kariura Y., Manago Y., Amano T., Wang B., Sekiguchi M., et al. Heterogeneity and potentiation of AMPA type of glutamate receptors in rat cultured microglia. Glia 2004, 47:68-77.
52. Hardy L.L., Wick D.A., Webb J.R. Conversion of tyrosine to the inflammation-associated analog 3'-nitrotyrosine at either TCR- or MHC-contact positions can profoundly affect recognition of the MHC class I-restricted epitope of lymphocytic choriomeningitis virus glycoprotein 33 by CD8 T cells. J. Immunol. 2008, 180:5956-5962.
53. Harms A.S., Cao S., Rowse A.L., Thome A.D., Li X., Mangieri L.R., et al. MHCII is required for alpha-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. J. Neurosci. 2013, 33:9592-9600.
54. Hatterer E., Touret M., Belin M.F., Honnorat J., Nataf S. Cerebrospinal fluid dendritic cells infiltrate the brain parenchyma and target the cervical lymph nodes under neuroinflammatory conditions. PLoS One 2008, 3:e3321.
55. Haydon P.G., Carmignoto G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol. Rev. 2006, 86:1009-1031.
56. He P., Zhong Z., Lindholm K., Berning L., Lee W., Lemere C., et al. Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice. J. Cell Biol. 2007, 178:829-841.
57. Hegg C.C., Hu S., Peterson P.K., Thayer S.A. Beta-chemokines and human immunodeficiency virus type-1 proteins evoke intracellular calcium increases in human microglia. Neuroscience 2000, 98:191-199.
58. Hirsch E.C., Hunot S. Neuroinflammation in Parkinson's disease: a target for neuroprotection?. Lancet Neurol. 2009, 8:382-397.
59. Hoek R.M., Ruuls S.R., Murphy C.A., Wright G.J., Goddard R., Zurawski S.M., et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000, 290:1768-1771.
60. Johnstone M., Gearing A.J., Miller K.M. A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced. J. Neuroimmunol. 1999, 93:182-193.
61. Kaushal V., Schlichter L.C. Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J. Neurosci. 2008, 28:2221-2230.
62. Kebir H., Kreymborg K., Ifergan I., Dodelet-Devillers A., Cayrol R., Bernard M., et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 2007, 13:1173-1175.
63. Kettenmann H., Hanisch U.K., Noda M., Verkhratsky A. Physiology of microglia. Physiol. Rev. 2011, 91:461-553.
64. Khan F., Ali R. Antibodies against nitric oxide damaged poly l-tyrosine and 3-nitrotyrosine levels in systemic lupus erythematosus. J. Biochem. Mol. Biol. 2006, 39:189-196.
65. Khan F., Siddiqui A.A. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus. Clin. Chim. Acta 2006, 370:100-107.
66. Kim C., Ho D.H., Suk J.E., You S., Michael S., Kang J., et al. Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat. Commun. 2013, 4:1562.
67. Kivisakk P., Trebst C., Liu Z., Tucky B.H., Sorensen T.L., Rudick R.A., et al. T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking. Clin. Exp. Immunol. 2002, 129:510-518.
68. Klareskog L., Stolt P., Lundberg K., Kallberg H., Bengtsson C., Grunewald J., et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006, 54:38-46.
69. Koizumi S., Shigemoto-Mogami Y., Nasu-Tada K., Shinozaki Y., Ohsawa K., Tsuda M., et al. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 2007, 446:1091-1095.
70. Kraft A.W., Hu X., Yoon H., Yan P., Xiao Q., Wang Y., et al. Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice. FASEB J. 2013, 27:187-198.
71. Kuno R., Yoshida Y., Nitta A., Nabeshima T., Wang J., Sonobe Y., et al. The role of TNF-alpha and its receptors in the production of NGF and GDNF by astrocytes. Brain Res. 2006, 1116:12-18.
72. Laman J.D., Weller R.O. Drainage of cells and soluble antigen from the CNS to regional lymph nodes. J. Neuroimmune Pharmacol. 2013, 8:840-856.
73. Lee H.J., Suk J.E., Patrick C., Bae E.J., Cho J.H., Rho S., et al. Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J. Biol. Chem. 2010, 285:9262-9272.
74. Lee S., Varvel N.H., Konerth M.E., Xu G., Cardona A.E., Ransohoff R.M., et al. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. Am. J. Pathol. 2010, 177:2549-2562.
75. Lee Y., Awasthi A., Yosef N., Quintana F.J., Xiao S., Peters A., et al. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 2012, 13:991-999.
76. Lehnardt S., Schott E., Trimbuch T., Laubisch D., Krueger C., Wulczyn G., et al. A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J. Neurosci. 2008, 28:2320-2331.
77. Letiembre M., Liu Y., Walter S., Hao W., Pfander T., Wrede A., et al. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern. Neurobiol. Aging 2009, 30:759-768.
78. Lewitus G.M., Schwartz M. Behavioral immunization: immunity to self-antigens contributes to psychological stress resilience. Mol. Psychiatry 2009, 14:532-536.
79. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 1999, 79:1431-1568.
80. Liu Y., Bando Y., Vargas-Lowy D., Elyaman W., Khoury S.J., Huang T., et al. CD200R1 agonist attenuates mechanisms of chronic disease in a murine model of multiple sclerosis. J. Neurosci. 2010, 30:2025-2038.
81. Lucin K.M., Wyss-Coray T. Immune activation in brain aging and neurodegeneration: too much or too little?. Neuron 2009, 64:110-122.
82. Lue L.F., Kuo Y.M., Beach T., Walker D.G. Microglia activation and anti-inflammatory regulation in Alzheimer's disease. Mol. Neurobiol. 2010, 41:115-128.
83. Lyons A., Downer E.J., Crotty S., Nolan Y.M., Mills K.H., Lynch M.A. CD200 ligand receptor interaction modulates microglial activation in vivo and in vitro: a role for IL-4. J. Neurosci. 2007, 27:8309-8313.
84. Lyons A., Downer E.J., Costello D.A., Murphy N., Lynch M.A. Dok2 mediates the CD200Fc attenuation of Abeta-induced changes in glia. J. Neuroinflammation 2012, 9:107.
85. Ma D., Jin S., Li E., Doi Y., Parajuli B., Noda M., et al. The neurotoxic effect of astrocytes activated with toll-like receptor ligands. J. Neuroimmunol. 2013, 254:10-18.
86. Matsuo K., Xiang Y., Nakamura H., Masuko K., Yudoh K., Noyori K., et al. Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach. Arthritis Res. Ther. 2006, 8:R175.
87. McAlpine F.E., Lee J.K., Harms A.S., Ruhn K.A., Blurton-Jones M., Hong J., et al. Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology. Neurobiol. Dis. 2009, 34:163-177.
88. McCoy M.K., Martinez T.N., Ruhn K.A., Szymkowski D.E., Smith C.G., Botterman B.R., et al. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease. J. Neurosci. 2006, 26:9365-9375.
89. Morganti J.M., Nash K.R., Grimmig B.A., Ranjit S., Small B., Bickford P.C., et al. The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease. J. Neurosci. 2012, 32:14592-14601.
90. Mott R.T., Ait-Ghezala G., Town T., Mori T., Vendrame M., Zeng J., et al. Neuronal expression of CD22: novel mechanism for inhibiting microglial proinflammatory cytokine production. Glia 2004, 46:369-379.
91. Muhammad S., Barakat W., Stoyanov S., Murikinati S., Yang H., Tracey K.J., et al. The HMGB1 receptor RAGE mediates ischemic brain damage. J. Neurosci. 2008, 28:12023-12031.
92. Nagyoszi P., Wilhelm I., Farkas A.E., Fazakas C., Dung N.T., Hasko J., et al. Expression and regulation of toll-like receptors in cerebral endothelial cells. Neurochem. Int. 2010, 57:556-564.
93. Nayak D., Zinselmeyer B.H., Corps K.N., McGavern D.B. In vivo dynamics of innate immune sentinels in the CNS. IntraVital 2012, 1:95-106.
94. Nikcevich K.M., Gordon K.B., Tan L., Hurst S.D., Kroepfl J.F., Gardinier M., et al. IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. J. Immunol. 1997, 158:614-621.
95. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318.
96. Noda M., Nakanishi H., Nabekura J., Akaike N. AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia. J. Neurosci. 2000, 20:251-258.
97. Noelker C., Morel L., Lescot T., Osterloh A., Alvarez-Fischer D., Breloer M., et al. Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease. Sci. Rep. 2013, 3:1393.
98. Ohmori H., Kanayama N. Immunogenicity of an inflammation-associated product, tyrosine nitrated self-proteins. Autoimmun. Rev. 2005, 4:224-229.
99. Ohnishi H., Kaneko Y., Okazawa H., Miyashita M., Sato R., Hayashi A., et al. Differential localization of Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 and CD47 and its molecular mechanisms in cultured hippocampal neurons. J. Neurosci. 2005, 25:2702-2711.
100. Orr C.F., Rowe D.B., Mizuno Y., Mori H., Halliday G.M. A possible role for humoral immunity in the pathogenesis of Parkinson's disease. Brain 2005, 128:2665-2674.
101. Ozinsky A., Underhill D.M., Fontenot J.D., Hajjar A.M., Smith K.D., Wilson C.B., et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:13766-13771.
102. Pabon M.M., Bachstetter A.D., Hudson C.E., Gemma C., Bickford P.C. CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease. J. Neuroinflammation 2011, 8:9.
103. Pacheco R., Gallart T., Lluis C., Franco R. Role of glutamate on T-cell mediated immunity. J. Neuroimmunol. 2007, 185:9-19.
104. Pacheco R., Riquelme E., Kalergis A.M. Emerging evidence for the role of neurotransmitters in the modulation of T cell responses to cognate ligands. Cent. Nerv. Syst. Agents Med. Chem. 2010, 10:65-83.
105. Pais T.F., Figueiredo C., Peixoto R., Braz M.H., Chatterjee S. Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathway. J. Neuroinflammation 2008, 5:43.
106. Panaro M.A., Lofrumento D.D., Saponaro C., De Nuccio F., Cianciulli A., Mitolo V., et al. Expression of TLR4 and CD14 in the central nervous system (CNS) in a MPTP mouse model of Parkinson's-like disease. Immunopharmacol. Immunotoxicol. 2008, 30:729-740.
107. Paolicelli R.C., Bolasco G., Pagani F., Maggi L., Scianni M., Panzanelli P., et al. Synaptic pruning by microglia is necessary for normal brain development. Science 2011, 333:1456-1458.
108. Papachroni K.K., Ninkina N., Papapanagiotou A., Hadjigeorgiou G.M., Xiromerisiou G., Papadimitriou A., et al. Autoantibodies to alpha-synuclein in inherited Parkinson's disease. J. Neurochem. 2007, 101:749-756.
109. Pashenkov M., Teleshova N., Kouwenhoven M., Smirnova T., Jin Y.P., Kostulas V., et al. Recruitment of dendritic cells to the cerebrospinal fluid in bacterial neuroinfections. J. Neuroimmunol. 2002, 122:106-116.
110. Pekny M., Wilhelmsson U., Pekna M. The dual role of astrocyte activation and reactive gliosis. Neurosci. Lett. 2014, 565:30-38.
111. Prodinger C., Bunse J., Kruger M., Schiefenhovel F., Brandt C., Laman J.D., et al. CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system. Acta Neuropathol. 2011, 121:445-458.
112. Qian L., Tan K.S., Wei S.J., Wu H.M., Xu Z., Wilson B., et al. Microglia-mediated neurotoxicity is inhibited by morphine through an opioid receptor-independent reduction of NADPH oxidase activity. J. Immunol. 2007, 179:1198-1209.
113. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55:453-462.
114. Qiu W.Q., Ye Z., Kholodenko D., Seubert P., Selkoe D.J. Degradation of amyloid beta-protein by a metalloprotease secreted by microglia and other neural and non-neural cells. J. Biol. Chem. 1997, 272:6641-6646.
115. Ransohoff R.M., Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 2012, 12:623-635.
116. Ransohoff R.M., Perry V.H. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 2009, 27:119-145.
117. Reale M., Iarlori C., Thomas A., Gambi D., Perfetti B., Di Nicola M., et al. Peripheral cytokines profile in Parkinson's disease. Brain Behav. Immun. 2009, 23:55-63.
118. Reboldi A., Coisne C., Baumjohann D., Benvenuto F., Bottinelli D., Lira S., et al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 2009, 10:514-523.
119. Reed-Geaghan E.G., Savage J.C., Hise A.G., Landreth G.E. CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. J. Neurosci. 2009, 29:11982-11992.
120. Reynolds A.D., Stone D.K., Mosley R.L., Gendelman H.E. Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets. J. Immunol. 2009, 182:4137-4149.
121. Reynolds A.D., Stone D.K., Hutter J.A., Benner E.J., Mosley R.L., Gendelman H.E. Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease. J. Immunol. 2010, 184:2261-2271.
122. Richard K.L., Filali M., Prefontaine P., Rivest S. Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. J. Neurosci. 2008, 28:5784-5793.
123. Rouach N., Koulakoff A., Abudara V., Willecke K., Giaume C. Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 2008, 322:1551-1555.
124. Schwartz M., Shaked I., Fisher J., Mizrahi T., Schori H. Protective autoimmunity against the enemy within: fighting glutamate toxicity. Trends Neurosci. 2003, 26:297-302.
125. Shechter R., Miller O., Yovel G., Rosenzweig N., London A., Ruckh J., et al. Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity 2013, 38:555-569.
126. Shimura H., Schlossmacher M.G., Hattori N., Frosch M.P., Trockenbacher A., Schneider R., et al. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science 2001, 293:263-269.
127. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 2012, 122:787-795.
128. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997, 388:839-840.
129. Sriram K., Matheson J.M., Benkovic S.A., Miller D.B., Luster M.I., O'Callaghan J.P. Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease. FASEB J. 2002, 16:1474-1476.
130. Stanimirovic D., Shapiro A., Wong J., Hutchison J., Durkin J. The induction of ICAM-1 in human cerebromicrovascular endothelial cells (HCEC) by ischemia-like conditions promotes enhanced neutrophil/HCEC adhesion. J. Neuroimmunol. 1997, 76:193-205.
131. Stolp H.B., Dziegielewska K.M. Review: role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases. Neuropathol. Appl. Neurobiol. 2009, 35:132-146.
132. Stone D.K., Kiyota T., Mosley R.L., Gendelman H.E. A model of nitric oxide induced alpha-synuclein misfolding in Parkinson's disease. Neurosci. Lett. 2012, 523:167-173.
133. Tahara K., Kim H.D., Jin J.J., Maxwell J.A., Li L., Fukuchi K. Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 2006, 129:3006-3019.
134. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
135. Takeuchi H., Mizuno T., Zhang G., Wang J., Kawanokuchi J., Kuno R., et al. Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport. J. Biol. Chem. 2005, 280:10444-10454.
136. Takeuchi H., Jin S., Wang J., Zhang G., Kawanokuchi J., Kuno R., et al. Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J. Biol. Chem. 2006, 281:21362-21368.
137. Tieu K., Ischiropoulos H., Przedborski S. Nitric oxide and reactive oxygen species in Parkinson's disease. IUBMB Life 2003, 55:329-335.
138. Vajkoczy P., Laschinger M., Engelhardt B. Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. J. Clin. Invest. 2001, 108:557-565.
139. Walker D.G., Dalsing-Hernandez J.E., Campbell N.A., Lue L.F. Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation. Exp. Neurol. 2009, 215:5-19.
140. Walter S., Letiembre M., Liu Y., Heine H., Penke B., Hao W., et al. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell. Physiol. Biochem. 2007, 20:947-956.
141. Wing K., Yamaguchi T., Sakaguchi S. Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation. Trends Immunol. 2011, 32:428-433.
142. Winner B., Jappelli R., Maji S.K., Desplats P.A., Boyer L., Aigner S., et al. In vivo demonstration that alpha-synuclein oligomers are toxic. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:4194-4199.
143. Wyss-Coray T., Loike J.D., Brionne T.C., Lu E., Anankov R., Yan F., et al. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat. Med. 2003, 9:453-457.
144. Yang Y., Weiner J., Liu Y., Smith A.J., Huss D.J., Winger R., et al. T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J. Exp. Med. 2009, 206:1549-1564.
145. Yirmiya R., Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 2011, 25:181-213.
146. Yu Z., Xu X., Xiang Z., Zhou J., Zhang Z., Hu C., et al. Nitrated alpha-synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats. PLoS One 2010, 5:e9956.
147. Zhang S., Wang X.J., Tian L.P., Pan J., Lu G.Q., Zhang Y.J., et al. CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease. J. Neuroinflammation 2011, 8:154.
148. Ziv Y., Ron N., Butovsky O., Landa G., Sudai E., Greenberg N., et al. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat. Neurosci. 2006, 9:268-275.
149. Zou J.Y., Crews F.T. TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition. Brain Res. 2005, 1034:11-24.